Dermavant Sciences Announces Appointment of Dr. Philip M. Brown as Chief Medical Officer Dr. Brown previously served as Head of Global Pharmaceutical Development at Galderma and has over 25 years of experience leading clinical development programsDermavant plans to initiate Phase 3...